http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2003507334-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55561 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0026 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-711 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-711 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-60 |
| filingDate | 1999-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2003-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2003507334-A |
| titleOfInvention | Plasma substitute composition |
| abstract | (57) [Summary]nThe present invention relates to medicaments, and more specifically, the present invention relates to serious acute and chronic disorders of the human body, wherein the disorders are indicative of immunodeficiency, altering the functional properties of blood or causing hypovolemia. And pharmaceutical preparations useful for the treatment of According to the present invention, there is provided a plasma substitute composition having an immunomodulatory effect. The present invention provides the use of certain biologically active ingredients of physiologically acceptable salts of DNA derivatives, preferably sodium salts obtained from animal sources such as sturgeon or salmon testes. Useful compositions for adjuvants stimulate hematopoiesis and myelopoiesis without any side effects or complications. |
| priorityDate | 1999-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 103.